Acetazolamide
- Product NDC
- 70934-926
- 11-digit product format
- 709340926
- Labeler code
- 70934
- Product ID
- 70934-926_ef180a84-4ed8-59d8-e053-2995a90af2d0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA211556
- Marketing category
- ANDA
- Marketing start
- 2021-12-02
- Marketing end
- 2023-02-28
- Substance
- ACETAZOLAMIDE
- Active strength
- 125 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-926-30 | 70934092630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-926-30) | 30 tablet | 2021-12-02 | 0000-00-00 | No | No | Current |